Tanai Therapeutics is developing a first-in-class oral therapeutic for obesity.
In stealth, more information will follow.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products
